The closing price of Yield10 Bioscience Inc (NASDAQ: YTEN) was $0.34 for the day, down -4.94% from the previous closing price of $0.36. In other words, the price has decreased by -$0.0178 from its previous closing price. On the day, 1366084 shares were traded.
Ratios:
Our analysis of YTEN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 8.54 whereas as Long-Term Debt/Eq ratio is at 4.36.
On September 10, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
National Securities Upgraded its Neutral to Buy on August 27, 2020, while the target price for the stock was maintained at $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 19 ’23 when SCHULER JACK W sold 36,000 shares for $0.21 per share. The transaction valued at 7,430 led to the insider holds 1,566,956 shares of the business.
SCHULER JACK W sold 35,000 shares of YTEN for $8,320 on Dec 08 ’23. The 10% Owner now owns 1,602,956 shares after completing the transaction at $0.24 per share. On Oct 06 ’23, another insider, SCHULER JACK W, who serves as the 10% Owner of the company, sold 37,931 shares for $0.30 each. As a result, the insider received 11,448 and left with 872,956 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, YTEN now has a Market Capitalization of 4.02M and an Enterprise Value of 4.58M. For the stock, the TTM Price-to-Sale (P/S) ratio is 27.33 while its Price-to-Book (P/B) ratio in mrq is 10.39. Its current Enterprise Value per Revenue stands at 10.19 whereas that against EBITDA is -0.33.
Stock Price History:
Over the past 52 weeks, YTEN has reached a high of $3.29, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is 0.2618, while the 200-Day Moving Average is calculated to be 0.6525.
Shares Statistics:
YTEN traded an average of 4.43M shares per day over the past three months and 12.67M shares per day over the past ten days. A total of 11.98M shares are outstanding, with a floating share count of 9.73M. Insiders hold about 18.81% of the company’s shares, while institutions hold 5.07% stake in the company. Shares short for YTEN as of Feb 29, 2024 were 290.52k with a Short Ratio of 0.07, compared to 50.15k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.42% and a Short% of Float of 2.65%.
Earnings Estimates
The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.3 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.31, while EPS last year was -$0.67. The consensus estimate for the next quarter is -$0.31, with high estimates of -$0.31 and low estimates of -$0.32.
Analysts are recommending an EPS of between -$1.88 and -$2.11 for the fiscal current year, implying an average EPS of -$1.99. EPS for the following year is -$1.19, with 2 analysts recommending between -$1.02 and -$1.36.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for YTEN’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $60k, resulting in an average revenue estimate of $80k. In the same quarter a year ago, actual revenue was $450k, down -82.20% from the average estimate.
